Before, we published the results of a new study that found psilocybin therapy to be four times more effective than antidepressants for treating major depression disorders (MDD). Staying within the theme of psilocybin research, we have news about a first-of-its-kind exploratory study that has Read More...
Back in July, we informed our readers that Oregon would officially vote on legalizing psychedelic psilocybin therapy. Fast forward to today, and the results of that vote are in: adults in Oregon can now legally access hallucinogenic mushrooms. This is a big deal. The Optimist Daily has long been Read More...
Back in August 2019, we published a small story about activists in Oregon working to decriminalize the use of magic mushrooms (psilocybin). Today, we’re here to tell you that these activists have taken a big step towards achieving their legalization goal. After more than a year of work and Read More...
Just months after we dedicated a week to the magnificent mushroom, the FDA has approved psilocybin, the hallucinogenic compound of magic mushrooms, as a Breakthrough Therapy for the second time this year. This designation means research can be fast-tracked into psilocybin’s application for Read More...
Lying on a bed in London’s Hammersmith hospital ingesting capsules of psilocybin, the active ingredient of magic mushrooms, Michael had little idea what would happen next. The 56-year-old part-time website developer from County Durham in northern England had battled depression for 30 years and Read More...
While big pharma may have a stranglehold on the market for antidepressants, Dr. Robin Carhart-Harris believes mushrooms could break that within the coming five to ten years. Carhart-Harris is one of the UK’s leading researchers on psilocybin mushrooms, and according to a recent study, magic Read More...
Psilocybin, the primary psychoactive compound in magic mushrooms, could soon be used in tandem with psychological support to help people suffering from depression by stimulating in them a more positive outlook on life. This follows a study in London which participants who were administered the Read More...